77 related articles for article (PubMed ID: 22808998)
1. Eudragit E100 as a drug carrier: the remarkable affinity of phosphate ester for dimethylamine.
Guzmán ML; Manzo RH; Olivera ME
Mol Pharm; 2012 Sep; 9(9):2424-33. PubMed ID: 22808998
[TBL] [Abstract][Full Text] [Related]
2. Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs.
Quinteros DA; Rigo VR; Kairuz AF; Olivera ME; Manzo RH; Allemandi DA
Eur J Pharm Sci; 2008 Jan; 33(1):72-9. PubMed ID: 18060747
[TBL] [Abstract][Full Text] [Related]
3. Preparation of Eudragit E100 microspheres by modified solvent evaporation method.
Singh V; Chaudhary AK
Acta Pol Pharm; 2011; 68(6):975-80. PubMed ID: 22125964
[TBL] [Abstract][Full Text] [Related]
4. Preparation of floating microspheres for fish farming.
Nepal PR; Chun MK; Choi HK
Int J Pharm; 2007 Aug; 341(1-2):85-90. PubMed ID: 17485183
[TBL] [Abstract][Full Text] [Related]
5. Interaction of a cationic acrylate polymer with caseins: biphasic effect of Eudragit E100 on the stability of casein micelles.
Ausar SF; Bianco ID; Castagna LF; Alasino RV; Beltramo DM
J Agric Food Chem; 2003 Jul; 51(15):4417-23. PubMed ID: 12848519
[TBL] [Abstract][Full Text] [Related]
6. Eudragit E100 surface activity and lipid interactions.
Alasino RV; Leonhard V; Bianco ID; Beltramo DM
Colloids Surf B Biointerfaces; 2012 Mar; 91():84-9. PubMed ID: 22093374
[TBL] [Abstract][Full Text] [Related]
7. Tailor-made release triggering from hot-melt extruded complexes of basic polyelectrolyte and poorly water-soluble drugs.
Kindermann C; Matthée K; Strohmeyer J; Sievert F; Breitkreutz J
Eur J Pharm Biopharm; 2011 Oct; 79(2):372-81. PubMed ID: 21596136
[TBL] [Abstract][Full Text] [Related]
8. Interaction between Eudragit® E100 and anionic drugs: addition of anionic polyelectrolytes and their influence on drug release performance.
Quinteros DA; Manzo RH; Allemandi DA
J Pharm Sci; 2011 Nov; 100(11):4664-73. PubMed ID: 21647887
[TBL] [Abstract][Full Text] [Related]
9. Controlled release formulation of ranitidine-containing montmorillonite and Eudragit E-100.
Joshi GV; Kevadiya BD; Bajaj HC
Drug Dev Ind Pharm; 2010 Sep; 36(9):1046-53. PubMed ID: 20545505
[TBL] [Abstract][Full Text] [Related]
10. Interaction and complex formation between catalase and cationic polyelectrolytes: chitosan and Eudragit E100.
Boeris V; Romanini D; Farruggia B; Picó G
Int J Biol Macromol; 2009 Aug; 45(2):103-8. PubMed ID: 19397924
[TBL] [Abstract][Full Text] [Related]
11. Reduced food interaction and enhanced gastrointestinal tolerability of a new system based on risedronate complexed with Eudragit E100: Mechanistic approaches from in vitro and in vivo studies.
Guzman ML; Soria EA; Laino C; Manzo RH; Olivera ME
Eur J Pharm Biopharm; 2016 Oct; 107():263-72. PubMed ID: 27418392
[TBL] [Abstract][Full Text] [Related]
12. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
[TBL] [Abstract][Full Text] [Related]
13. Amphipathic and membrane-destabilizing properties of the cationic acrylate polymer Eudragit E100.
Alasino RV; Ausar SF; Bianco ID; Castagna LF; Contigiani M; Beltramo DM
Macromol Biosci; 2005 Mar; 5(3):207-13. PubMed ID: 15768439
[TBL] [Abstract][Full Text] [Related]
14. Interaction of tannase from Aspergillus niger with polycations applied to its primary recovery.
Durán LV; Spelzini D; Boeris V; Aguilar CN; Picó GA
Colloids Surf B Biointerfaces; 2013 Oct; 110():480-4. PubMed ID: 23706551
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
[TBL] [Abstract][Full Text] [Related]
16. Star-shaped nano-conjugates of cisplatin with high drug payload.
Kowalczuk A; Stoyanova E; Mitova V; Shestakova P; Momekov G; Momekova D; Koseva N
Int J Pharm; 2011 Feb; 404(1-2):220-30. PubMed ID: 21078377
[TBL] [Abstract][Full Text] [Related]
17. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
Kaur K; Kim K
Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of interpolyelectrolyte complexes of Eudragit E100 with Eudragit L100.
Moustafine RI; Kabanova TV; Kemenova VA; Van den Mooter G
J Control Release; 2005 Mar; 103(1):191-8. PubMed ID: 15710510
[TBL] [Abstract][Full Text] [Related]
19. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
Shaheen SM; Takezoe K; Yamaura K
Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
[TBL] [Abstract][Full Text] [Related]
20. Deeper insight into the drug release mechanisms in Eudragit RL-based delivery systems.
Glaessl B; Siepmann F; Tucker I; Rades T; Siepmann J
Int J Pharm; 2010 Apr; 389(1-2):139-46. PubMed ID: 20105459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
